Amedisys Inc (AMED) Stake Lifted by New York State Common Retirement Fund

New York State Common Retirement Fund grew its holdings in Amedisys Inc (NASDAQ:AMED) by 61.8% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 49,500 shares of the health services provider’s stock after acquiring an additional 18,900 shares during the quarter. New York State Common Retirement Fund owned about 0.15% of Amedisys worth $2,770,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Federated Investors Inc. PA increased its holdings in shares of Amedisys by 2.3% in the 2nd quarter. Federated Investors Inc. PA now owns 1,929 shares of the health services provider’s stock valued at $122,000 after acquiring an additional 44 shares during the last quarter. State Board of Administration of Florida Retirement System increased its holdings in shares of Amedisys by 0.5% in the 2nd quarter. State Board of Administration of Florida Retirement System now owns 19,658 shares of the health services provider’s stock valued at $1,235,000 after acquiring an additional 93 shares during the last quarter. Suntrust Banks Inc. increased its holdings in shares of Amedisys by 4.3% in the 2nd quarter. Suntrust Banks Inc. now owns 5,702 shares of the health services provider’s stock valued at $358,000 after acquiring an additional 237 shares during the last quarter. ETRADE Capital Management LLC increased its holdings in shares of Amedisys by 4.7% in the 2nd quarter. ETRADE Capital Management LLC now owns 6,409 shares of the health services provider’s stock valued at $403,000 after acquiring an additional 285 shares during the last quarter. Finally, The Manufacturers Life Insurance Company increased its holdings in shares of Amedisys by 1.9% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 22,348 shares of the health services provider’s stock valued at $1,404,000 after acquiring an additional 410 shares during the last quarter. Institutional investors and hedge funds own 94.44% of the company’s stock.

AMED has been the topic of a number of recent analyst reports. Craig Hallum reiterated a “buy” rating and issued a $68.00 price objective (up previously from $55.00) on shares of Amedisys in a report on Thursday, November 9th. SunTrust Banks reiterated a “buy” rating and issued a $70.00 price objective on shares of Amedisys in a report on Friday, November 10th. Mizuho reiterated a “buy” rating and issued a $65.00 price objective (up previously from $55.00) on shares of Amedisys in a report on Wednesday, November 8th. Benchmark upgraded Amedisys from a “hold” rating to a “buy” rating and set a $56.00 price objective on the stock in a report on Thursday, November 2nd. Finally, Jefferies Group restated a “buy” rating and set a $60.00 price target on shares of Amedisys in a research note on Thursday, October 12th. Six equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $61.00.

Amedisys Inc (NASDAQ AMED) opened at $52.71 on Friday. The stock has a market capitalization of $1,800.68, a P/E ratio of 42.17, a P/E/G ratio of 1.28 and a beta of 0.70. The company has a debt-to-equity ratio of 0.16, a quick ratio of 1.33 and a current ratio of 1.33. Amedisys Inc has a 12 month low of $42.05 and a 12 month high of $65.91.

Amedisys (NASDAQ:AMED) last released its quarterly earnings results on Tuesday, November 7th. The health services provider reported $0.56 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.54 by $0.02. The firm had revenue of $380.20 million for the quarter, compared to the consensus estimate of $384.59 million. Amedisys had a return on equity of 14.68% and a net margin of 2.88%. The firm’s quarterly revenue was up 5.1% compared to the same quarter last year. During the same quarter last year, the business posted $0.36 EPS. analysts expect that Amedisys Inc will post 2.24 earnings per share for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Amedisys Inc (AMED) Stake Lifted by New York State Common Retirement Fund” was first posted by Community Financial News and is the property of of Community Financial News. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece of content can be accessed at https://www.com-unik.info/2017/12/30/amedisys-inc-amed-stake-lifted-by-new-york-state-common-retirement-fund.html.

Amedisys Company Profile

Amedisys, Inc is a healthcare services company. The Company’s segments are Home Health, Hospice, Personal Care and Other. The Company is a provider of home health, hospice and personal care services. As of December 31, 2016, the Company owned and operated 327 Medicare-certified home healthcare centers, 79 Medicare-certified hospice care centers and 14 personal-care care centers in 34 states within the United States and the District of Columbia.

Institutional Ownership by Quarter for Amedisys (NASDAQ:AMED)

Receive News & Ratings for Amedisys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amedisys and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit